Tag:
B ჰეპატიტი
News
The FDA has approved a new hepatitis B drug that offers patients a chance to end long-term treatment.
The U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen), a hepatitis B drug developed by the British pharmaceutical company GSK. The new...
Internal Medicine
Prospects for Functional Cure in Chronic Hepatitis B
Approximately 300 million people worldwide live with chronic Hepatitis B; however, fewer than 1% of them achieve a complete cure. Current medications effectively inhibit...